Hemrajani Rekha 4
4 · MAXCYTE, INC. · Filed Mar 21, 2023
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Hemrajani Rekha
Director
Transactions
- Award
Stock Option (right to buy)
2023-03-20+40,000→ 40,000 totalExercise: $4.19Exp: 2033-03-19→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. 23,333 of the shares underlying this option vested on March 20, 2023 and the remaining 16,667 shares will vest in 15 equal monthly installments thereafter, beginning on April 14, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.